Risk. From the time we wake up, we are faced with risks. Knowingly or not, our waking hours are spent trying to either eliminate or mitigate those risks.
The UK has given official notice that they will withdraw from the EU. With Brexit seemingly moving ahead, Bart Cobert looks at its effects on the world of pharmacovigilance.
Closely-tied Medical Information and Drug Safety departments, with a seamless adverse event intake and hand-off processs, offer better quality control, scalability and risk mitigation.
As the saying goes, children are not small adults. Thus the approach of pharmacovigilance to AEs in children needs to be different from that in adults.
Every couple of years, the pharmacology world reads about a phase I trial that has significant problems or is a frank disaster.
Training pharmaceutical representatives to understand — and maximize the benefits of — software they’re using on the job is a necessary component of any pharmaceutical sales program.
The advantages and disadvantages of remote audits and inspections – also called virtual inspections, distant inspections, paper inspections, web inspections, and telephone inspections.
Soniya Patel highlights the importance of medical escalation procedures during a clinical trial.
Susan Mattson & Ed Chase explore some of the areas hindering pharma companies from becoming fully patient-centered, and how to overcome these challenges.
